Jain Global’s United Therapeutics UTHR Stock Holding History

Jain Global’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,794	Closed	-$8.72M	–	1538
2025 Q3	$8.72M	Buy	+20,794	New	+$6.99M	0.04%	257

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Jain Global's UTHR Position: Q4 2025 in Review

Jain Global sold out of United Therapeutics (UTHR) in Q4 2025, closing a stake of 20,794 shares — an estimated $8.72M sold.

Jain Global first reported a position in UTHR in Q3 2025 and held it in 1 quarter. The position peaked at $8.72M in Q3 2025. 837 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

Jain Global reported no remaining United Therapeutics position as of Q4 2025 after selling out during the quarter.
Jain Global sold 20,794 United Therapeutics shares in Q4 2025, an estimated $8.72M.
Jain Global first reported a position in United Therapeutics in Q3 2025 and held it in 1 quarter.
Jain Global's United Therapeutics position peaked at $8.72M in Q3 2025.
837 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on Jain Global's 13F filing for Q4 2025, filed 17 Feb 2026.